Listeria monocytogenes pericarditis in a chronically hemodialyzed patient.
We describe the third documented case of Listeria monocytogenes pericarditis. This occurred in a 54-year-old woman with end-stage renal failure on chronic hemodialysis. Her initial presentation was one of Listeria monocytogenes bacteremia, which apparently responded to two weeks of cefazolin sodium therapy. After cessation of therapy the patient returned with Listeria monocytogenes pericarditis, this responding completely to four weeks of erythromycin therapy. We could not rule out coexisting endocarditis, especially since we found high levels of circulating immune complexes which subsided as the patient's condition improved. Further immunological studies displayed a decrease in cellular functions. This case illustrates the importance of Listeria monocytogenes as a human pathogen in immunocompromised patients. Listeria should be included among the potential causative agents of pericarditis in such patients.
D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008088:Listeriosis / Q000188:drug therapy / Q000276:immunology; D008875:Middle Aged; D010493:Pericarditis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D006435:Renal Dialysis
D004917:Erythromycin